ArticleActa pharmaceutica Sinica. B2026
TeroACT: A terpenoid bioactivity landscape and discovery platform.
Article in Acta pharmaceutica Sinica. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial of special column on machine learning in drug discovery.Acta pharmaceutica Sinica. B · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Terpenoids exhibit diverse biological activities and thus have a wide range of pharmacological applications. In modern drug discovery, data-driven deep models play a crucial role in facilitating efficient feature representation and knowledge inference. To explore the uncharted bioactivity space of terpenoids, the construction of a multi-dimensional relational terpenoid database is essential for mapping terpenoid-bioactivity profiles. In this study, we first constructed a large-scale biological knowledge graph by integrating various data types, including terpenoid compounds, protein targets, cellular targets, genes, diseases, and their interrelationships. Subsequently, we developed a network-based disease prediction model, as well as optimized multiple compound-protein interaction prediction tools to extend the framework for activity research. These resources have been deployed on a user-friendly web platform (TeroACT) accessible at: http://terokit.qmclab.com/teroact/. Using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.